Biomarker analysis using fresh biopsy samples

• Research type

  Research Study

• Full title

  Biomarker analysis using fresh prostate tumor biopsy samples

• IRAS ID

  248492

• Contact name

  Colin Mulholland

• Contact email

  colin.mulholland@westerntrust.hscni.net

• Sponsor organisation

  Lantern Pharma

• Duration of Study in the UK

  4 years, 0 months, 0 days

• Research summary

  Lantern Pharma is developing the novel drug, LP-184 (HUMAF), for prostate cancer. Preliminary biomarker analyses using cell line data have identified molecular profiles that correlate with drug sensitivity. We plan to obtain fresh prostate tumor biopsies for the analysis of drug sensitivity and molecular markers to confirm and extend the cell line-based biomarker analysis.

• REC name

  HSC REC A

• REC reference

  19/NI/0034

• Date of REC Opinion

  15 Apr 2019

• REC opinion

  Further Information Favourable Opinion